Pacira BioSciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCRX and other ETFs, options, and stocks.About PCRX
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam.
PCRX Key Statistics
Stock Snapshot
With a market cap of 1.04B, Pacira BioSciences(PCRX) trades at $24.22. The stock has a price-to-earnings ratio of 54.23.
On 2025-12-05, Pacira BioSciences(PCRX) stock moved within a range of $23.92 to $24.32. With shares now at $24.22, the stock is trading +1.3% above its intraday low and -0.4% below the session's peak.
Trading volume for Pacira BioSciences(PCRX) stock has reached 163.3K, versus its average volume of 719.54K.
Over the past 52 weeks, Pacira BioSciences(PCRX) stock has traded between a high of $27.64 and a low of $18.17.
Over the past 52 weeks, Pacira BioSciences(PCRX) stock has traded between a high of $27.64 and a low of $18.17.
PCRX News
In early December 2025, Pacira BioSciences reported 12‑month results from a 30‑patient randomized pilot study showing its iovera° cryoneurolysis treatment produ...
